Manahan
David E. Manahan, St. Paul, MN US
Patent application number | Description | Published |
---|---|---|
20100198309 | ISOLATION CIRCUITRY AND METHOD FOR GRADIENT FIELD SAFETY IN AN IMPLANTABLE MEDICAL DEVICE - An implantable medical device is provided for isolating an elongated medical lead from internal device circuitry in the presence of a gradient magnetic or electrical field. The device includes an isolation circuit adapted to operatively connect an internal circuit to the medical lead in a first operative state and to electrically isolate the medical lead from the internal circuit in a second operative state. | 08-05-2010 |
20110106217 | CONTROLLING EFFECTS CAUSED BY EXPOSURE OF AN IMPLANTABLE MEDICAL DEVICE TO A DISRUPTIVE ENERGY FIELD - Techniques are described for controlling effects caused when an implantable medical device (IMD) is subject to a disruptive energy field. The IMD may include an implantable lead that includes one or more electrodes. The IMD may further include a first component having a parasitic inductance. The IMD may further include a second component having a reactance. In some examples, the reactance of the second component may be selected based on the parasitic inductance of the first component such that an amount of energy reflected along the lead in response to energy produced by an electromagnetic energy source is below a selected threshold. In additional examples, the parasitic inductance of the first component and the reactance of the second component are configured such that an amount of energy reflected along the lead in response to a frequency of electromagnetic energy is below a selected threshold. | 05-05-2011 |
20110106218 | CONTROLLING EFFECTS CAUSED BY EXPOSURE OF AN IMPLANTABLE MEDICAL DEVICE TO A DISRUPTIVE ENERGY FIELD - Techniques are described for controlling effects caused when an implantable medical device (IMD) is subject to a disruptive energy field. The IMD may include an implantable lead that includes one or more electrodes. The IMD may further include a first component having a parasitic inductance. The IMD may further include a second component having a reactance. In some examples, the reactance of the second component may be selected based on the parasitic inductance of the first component such that an amount of energy reflected along the lead in response to energy produced by an electromagnetic energy source is below a selected threshold. In additional examples, the parasitic inductance of the first component and the reactance of the second component are configured such that an amount of energy reflected along the lead in response to a frequency of electromagnetic energy is below a selected threshold. | 05-05-2011 |
Matthew S. Manahan, Morristown, NJ US
Patent application number | Description | Published |
---|---|---|
20110250644 | FEED SUPPLEMENT FOR MAMMALIAN CELL CULTURE AND METHODS OF USE - An improved feed supplement for culture of mammalian cells used to produce proteins is provided. The improved supplement is devoid of animal-derived components and protein hydrolysates. The invention also provides methods of using the supplement in production of a therapeutic proteins, such as an antibody. In some embodiments, the antibody is an anti-human IL-23p19 antibody. | 10-13-2011 |
Michael W. Manahan, Bowling Green, OH US
Patent application number | Description | Published |
---|---|---|
20100181371 | Tamper evident label - A tamper-evident label for a carton having one flap or two opposing flaps includes a pair of end portions each having adhesive or other means for fastening to span the edge of one flap or opposing flaps of the carton. A central area between the end portions defines one or more strips which overlie an edge of one or both flaps. The central area defining the strips is unadhereable to the flaps and are in a condition such that, upon cutting therethrough to form ends on said strips, the ends will be displaced from the strip ends on the opposite sides of the cut. | 07-22-2010 |
Peter R. Manahan, New York CA
Patent application number | Description | Published |
---|---|---|
20120331460 | Centrally Controlled Proximity Based Software Installation - An illustrative embodiment of a computer-implemented process for a centrally controlled proximity based software installation receives a request to install a software package, sends a list of machines associated with the received request to a rules engine and generates a set of proximity groups using the list of machines. The computer-implemented process uploads the software package of the received request to a selected machine within a proximity group of the set of proximity groups, instructs the selected machine to install the software package and instructs the remaining machines associated with the proximity group of the selected machine to download the software package from the selected machine and to install the software package. Responsive to a determination that no more requests exist, the computer-implemented process reports to a central installer. | 12-27-2012 |